Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Girma

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|December 15, 1986
Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagenW P Houdijk, J P Girma, J A van Mourik, et al.
Thrombosis Research|May 1, 1978
"Variants" of von Willebrand's disease. Demonstration of a decreased antigenic reactivity by immunoradiometric assayN Ardaillou, J P Girma, D Meyer, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1988
von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein IbE Fressinaud, D Baruch, J P Girma, et al.
Thrombosis and Haemostasis|December 7, 1992
Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein IbJ P Girma, E Fressinaud, O Christophe, et al.
Thrombosis and Haemostasis|March 30, 2000
Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand diseaseH Tout, B Obert, A Houllier, et al.
Blood|June 20, 1998
Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factorH Depraetere, N Ajzenberg, J P Girma, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretionA Hommais, A Stépanian, E Fressinaud, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Total deficiency of specific von Willebrand factor-cleaving protease and recovery following plasma therapy in one patient with hemolytic-uremic syndromeA Veyradier, F Brivet, M Wolf, et al.
Thrombosis and Haemostasis|August 24, 1999
New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factorA Veyradier, A L Jumilly, A S Ribba, et al.
Circulation|November 15, 2000
Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertensionA Veyradier, T Nishikubo, M Humbert, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|December 15, 1986
Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagenW P Houdijk, J P Girma, J A van Mourik, et al.
Thrombosis Research|May 1, 1978
"Variants" of von Willebrand's disease. Demonstration of a decreased antigenic reactivity by immunoradiometric assayN Ardaillou, J P Girma, D Meyer, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1988
von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein IbE Fressinaud, D Baruch, J P Girma, et al.
Thrombosis and Haemostasis|December 7, 1992
Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein IbJ P Girma, E Fressinaud, O Christophe, et al.
Thrombosis and Haemostasis|March 30, 2000
Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand diseaseH Tout, B Obert, A Houllier, et al.
Blood|June 20, 1998
Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factorH Depraetere, N Ajzenberg, J P Girma, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretionA Hommais, A Stépanian, E Fressinaud, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Total deficiency of specific von Willebrand factor-cleaving protease and recovery following plasma therapy in one patient with hemolytic-uremic syndromeA Veyradier, F Brivet, M Wolf, et al.
Thrombosis and Haemostasis|August 24, 1999
New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factorA Veyradier, A L Jumilly, A S Ribba, et al.
Circulation|November 15, 2000
Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertensionA Veyradier, T Nishikubo, M Humbert, et al.
Pageof 7